People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Manufacturing, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Material Hybrid Manufacturing Inc | — | Manufacturing | Series A | $8.1M | $23.9M | 2025 |
| Eclipse Therapeutics, Inc. | — | Other | Seed | $2.8M | $51.6M | 2011 |
| Bvo 1 Llc | — | Other | Pre-Seed | $250K | $607K | 2025 |
Christopher Reyes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Reyes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Lim | 1 | 9 |
| Peter Chu | 1 | 3 |
| Jordan S. Kretchmer | 1 | 2 |
| Kathryn Hicks | 1 | 1 |
| Reuben Brunson | 1 | 1 |
| Gabriel Elias | 1 | 1 |
| Marvin Stockwell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.